1.Magnitude and Duration of Serum Neutralizing Antibody Titers Induced by a Third mRNA COVID-19 Vaccination against Omicron BA.1 in Older Individuals
Jun-Sun PARK ; Jaehyun JEON ; Jihye UM ; Youn Young CHOI ; Min-Kyung KIM ; Kyung-Shin LEE ; Ho Kyung SUNG ; Hee-Chang JANG ; BumSik CHIN ; Choon Kwan KIM ; Myung-don OH ; Chang-Seop LEE
Infection and Chemotherapy 2024;56(1):25-36
Background:
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant (B.1.1.529) is dominating coronavirus disease 2019 (COVID-19) worldwide. The waning protective effect of available vaccines against the Omicron variant is a critical public health issue. This study aimed to assess the impact of the third COVID-19 vaccination on immunity against the SARS-CoV-2 Omicron BA.1 strain in older individuals.
Materials and Methods:
Adults aged ≥60 years who had completed two doses of the homologous COVID-19 vaccine with either BNT162b2 (Pfizer/BioNTech, New York, NY, USA, BNT) or ChAdOx1 nCoV (SK bioscience, Andong-si, Gyeongsangbuk-do, Korea, ChAd) were registered to receive the third vaccination. Participants chose either BNT or mRNA-1273 (Moderna, Norwood, MA, USA, m1273) mRNA vaccine for the third dose and were categorized into four groups: ChAd/ChAd/BNT, ChAd/ChAd/m1273, BNT/BNT/BNT, and BNT/BNT/m1273. Four serum specimens were obtained from each participant at 0, 4, 12, and 24 weeks after the third dose (V1, V2, V3, and V4, respectively).Serum-neutralizing antibody (NAb) activity against BetaCoV/Korea/KCDC03/2020 (NCCP43326, ancestral strain) and B.1.1.529 (NCCP43411, Omicron BA.1 variant) was measured using plaque reduction neutralization tests. A 50% neutralizing dilution (ND 50 ) >10 was considered indicative of protective NAb titers.
Results:
In total, 186 participants were enrolled between November 24, 2021, and June 30, 2022. The respective groups received the third dose at a median (interquartile range [IQR]) of 132 (125 - 191), 123 (122 - 126), 186 (166 -193), and 182 (175 - 198) days after the second dose. Overall, ND 50 was lower at V1 against Omicron BA.1 than against the ancestral strain. NAb titers against the ancestral strain and Omicron BA.1 variant at V2 were increased at least 30-fold (median [IQR], 1235.35 [1021.45 - 2374.65)] and 129.8 [65.3 - 250.7], respectively). ND 50 titers against the ancestral strain and Omicron variant did not differ significantly among the four groups (P= 0.57). NAb titers were significantly lower against the Omicron variant than against the ancestral strain at V3 (median [IQR], 36.4 (17.55 - 75.09) vs. 325.9 [276.07 - 686.97]; P = 0.012). NAb titers against Omicron at V4 were 16 times lower than that at V3. Most sera exhibited a protective level (ND 50 >10) at V4 (75.0% [24/32], 73.0% [27/37], 73.3% [22/30], and 70.6% [12/17] in the ChAd/ChAd/BNT, ChAd/ChAd/m1273, BNT/BNT/BNT, and BNT/BNT/m1273 groups, respectively), with no significant differences among groups (P = 0.99).
Conclusion
A third COVID-19 mRNA vaccine dose restored waning NAb titers against Omicron BA.1. Our findings support a third-dose vaccination program to prevent the waning of humoral immunity to SARS-CoV-2.
2.2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism
Jeonghoon HA ; Jung Hwan PARK ; Kyoung Jin KIM ; Jung Hee KIM ; Kyong Yeun JUNG ; Jeongmin LEE ; Jong Han CHOI ; Seung Hun LEE ; Namki HONG ; Jung Soo LIM ; Byung Kwan PARK ; Jung-Han KIM ; Kyeong Cheon JUNG ; Jooyoung CHO ; Mi-kyung KIM ; Choon Hee CHUNG ; ;
Endocrinology and Metabolism 2023;38(6):597-618
Primary aldosteronism (PA) is a common, yet underdiagnosed cause of secondary hypertension. It is characterized by an overproduction of aldosterone, leading to hypertension and/or hypokalemia. Despite affecting between 5.9% and 34% of patients with hypertension, PA is frequently missed due to a lack of clinical awareness and systematic screening, which can result in significant cardiovascular complications. To address this, medical societies have developed clinical practice guidelines to improve the management of hypertension and PA. The Korean Endocrine Society, drawing on a wealth of research, has formulated new guidelines for PA. A task force has been established to prepare PA guidelines, which encompass epidemiology, pathophysiology, clinical presentation, diagnosis, treatment, and follow-up care. The Korean clinical guidelines for PA aim to deliver an evidence-based protocol for PA diagnosis, treatment, and patient monitoring. These guidelines are anticipated to ease the burden of this potentially curable condition.
3.Brain Abscess Caused by Vancomycin-Resistant Enterococci.
SulKi LEE ; Sang Won HA ; Un Kyu YUN ; In Ha WHANG ; Sang Woo HAN ; Seung Min KIM ; YoungSoon YANG ; Jeoung Ho HAN ; Inho OH ; Choon Kwan KIM
Journal of the Korean Neurological Association 2017;35(2):108-110
No abstract available.
Brain Abscess*
;
Brain*
;
Vancomycin-Resistant Enterococci*
4.Trends in Microorganisms Isolated from Blood Cultures at a Veterans Hospital from 2012 to 2015.
Misuk JI ; Youn Mi CHOI ; Eunsin BAE ; Choon Kwan KIM
Journal of Laboratory Medicine and Quality Assurance 2017;39(3):141-146
Blood culture is important to detecting bacteremia and fungemia in patients with suspected sepsis. We observed a four-year trend of blood culture isolates in the frequency by age group and in vitro antimicrobial susceptibility patterns obtained at VHS Medical Center, the largest veterans hospital in Korea. Blood cultures collected between 2012 and 2015 were analysed retrospectively. Of 68,352 blood specimens, 7,901 isolates were identified during the study period. Seventy-two percent of the isolates were gram-positive cocci, 18% were gram-negative rods, and 6% were fungi. The frequency of bacteremia/fungemia in patients who were 80–89 years old was 43.8%, the highest rate among all age groups, and the mean age of patients diagnosed by blood culture was 77 years old. Coagulase-negative staphylococcus (52.3%), Staphylococcus aureus (8.3%), enterococci (7.5%), Escherichia coli (6.4%), and Klebsiella pneumoniae (3.9%) were the bacteria most commonly isolated. The percentage of methicillin-resistant S . aureus increased in 2015 (76%) relative to that in 2012–2014 (63%–65%), and that of vancomycin-resistant Enterococcus faecium was 17%–22% with no significant changes through time. Among the gram-negative isolates, the ciprofloxacin resistance rate increased to 51.4% (E. coli ) and 31.1% (K. pneumoniae ) in 2015, but imipenem or ertapenem resistance was still very rare, with resistance rates of less than 0.5%. Acinetobacter baumannii showed a high rate of resistance (over 70%) to imipenem and ciprofloxacin throughout the study. In Pseudomonas aeruginosa , the resistance rates of imipenem and ciprofloxacin increased dramatically over time. This analysis confirmed a decrease in antimicrobial susceptibility of gram-negative rods isolated by blood culture.
Acinetobacter baumannii
;
Bacteremia
;
Bacteria
;
Ciprofloxacin
;
Enterococcus faecium
;
Escherichia coli
;
Fungemia
;
Fungi
;
Gram-Positive Cocci
;
Hospitals, Veterans*
;
Humans
;
Imipenem
;
In Vitro Techniques
;
Klebsiella pneumoniae
;
Korea
;
Methicillin Resistance
;
Pneumonia
;
Pseudomonas aeruginosa
;
Retrospective Studies
;
Sepsis
;
Staphylococcus
;
Staphylococcus aureus
;
Veterans*
5.Acute toxicity and cytotoxicity evaluation of Dendrobium moniliforme aqueous extract in vivo and in vitro.
Mu Jin LEE ; Ho Kyung JUNG ; Min Suk KIM ; Ji Hun JANG ; Mi Ok SIM ; Tea Mook KIM ; Ho PARK ; Byung Kwan AHN ; Hyun Woo CHO ; Jung Hee CHO ; Won Seok JUNG ; Jong Choon KIM
Laboratory Animal Research 2016;32(3):144-150
Dendrobium moniliforme (L.) Sw., an herb of the Orchidaceae family, has long been used in traditional medicine to strengthen bones, nourish the stomach, and promote the production of bodily fluid. Recently, polysaccharides isolated from Dendrobium have been used in functional foods and nutraceutical products. A traditional method to process Dendrobium is to soak fresh stems in an ethanol solution, which is the most important factor to ensure high yields of aqueous-extractable polysaccharides. The present study was carried out to investigate the potential acute toxicity of D. moniliforme aqueous extract (DMAE), by a single oral dose in Sprague-Dawley rats. The test article was orally administered once by gavage to male and female rats at doses of 0, 2,500, and 5,000 mg/kg body weight (n=5 male and female rats for each dose). Throughout the study period, no treatment-related deaths were observed and no adverse effects were noted in clinical signs, body weight, food consumption, serum biochemistry, organ weight, or gross findings at any dose tested. The results show that a single oral administration of DMAE did not induce any toxic effects at a dose below 5,000 mg/kg in rats, and the minimal lethal dose was considered to be over 5,000 mg/kg body weight for both sexes. With respect to cytotoxicity, the cell viability of human embryonic kidney (HEK293) cells was less than 50% when the cells were treated with 10 mg/mL aqueous extract for 24 h.
Administration, Oral
;
Animals
;
Biochemistry
;
Body Weight
;
Cell Survival
;
Dendrobium*
;
Dietary Supplements
;
Ethanol
;
Female
;
Functional Food
;
Humans
;
In Vitro Techniques*
;
Kidney
;
Male
;
Medicine, Traditional
;
Methods
;
Orchidaceae
;
Organ Size
;
Polysaccharides
;
Rats
;
Rats, Sprague-Dawley
;
Stomach
6.Increased Risk of Asymptomatic Gallstones in Patients With Ulcerative Colitis.
Jung Hoon HA ; Young Sook PARK ; Choon Sik SEON ; Byung Kwan SON ; Sang Bong AHN ; Young Kwan JO ; Seong Hwan KIM ; Yun Ju JO ; Jung Hwan KIM ; Jee Hye HAN ; Yoon Young JUNG ; Sook Hee CHUNG
Intestinal Research 2015;13(2):122-127
BACKGROUND/AIMS: The relationship between Crohn's disease and gallstones is established. However, the prevalence and risk factors for gallstones in patients with ulcerative colitis (UC) are not yet well understood. The aim of this study was to evaluate the prevalence and risk factors of gallstones in patients with UC. METHODS: This study was a retrospective single center study. A total of 87 patients with UC and 261 healthy controls were enrolled. Age, sex, and body mass index were matched. To investigate risk factors, the extent of UC, duration of disease, number of hospital admissions, and number of steroid treatments in patients with UC were evaluated. RESULTS: The prevalence of gallstones in patients with UC was 13.8%, whereas that in healthy controls was only 3.1% (P<0.001). For patients with UC, patients > or =50 years of age had a 3.6-times higher risk of gallstones compared to that in those <50 years of age, and the difference was statistically significant (odds ratio, 3.60; confidence interval, 1.03-12.61) in univariate analysis. There were no statistically significant disease-related risk factors for gallstones in UC patients. CONCLUSIONS: This is the first study of gallstone prevalence in Korean UC patients. In this study, patients with UC had a higher prevalence of gallstones compared to that in well-matched healthy controls. Age seemed to be a possible risk factor, and more studies are needed. Further prospective, large-scale studies will be required to confirm the risk factors for gallstones in UC patients.
Asymptomatic Diseases
;
Body Mass Index
;
Colitis, Ulcerative*
;
Crohn Disease
;
Gallstones*
;
Humans
;
Prevalence
;
Retrospective Studies
;
Risk Factors
7.Increased Risk of Asymptomatic Gallstones in Patients With Ulcerative Colitis.
Jung Hoon HA ; Young Sook PARK ; Choon Sik SEON ; Byung Kwan SON ; Sang Bong AHN ; Young Kwan JO ; Seong Hwan KIM ; Yun Ju JO ; Jung Hwan KIM ; Jee Hye HAN ; Yoon Young JUNG ; Sook Hee CHUNG
Intestinal Research 2015;13(2):122-127
BACKGROUND/AIMS: The relationship between Crohn's disease and gallstones is established. However, the prevalence and risk factors for gallstones in patients with ulcerative colitis (UC) are not yet well understood. The aim of this study was to evaluate the prevalence and risk factors of gallstones in patients with UC. METHODS: This study was a retrospective single center study. A total of 87 patients with UC and 261 healthy controls were enrolled. Age, sex, and body mass index were matched. To investigate risk factors, the extent of UC, duration of disease, number of hospital admissions, and number of steroid treatments in patients with UC were evaluated. RESULTS: The prevalence of gallstones in patients with UC was 13.8%, whereas that in healthy controls was only 3.1% (P<0.001). For patients with UC, patients > or =50 years of age had a 3.6-times higher risk of gallstones compared to that in those <50 years of age, and the difference was statistically significant (odds ratio, 3.60; confidence interval, 1.03-12.61) in univariate analysis. There were no statistically significant disease-related risk factors for gallstones in UC patients. CONCLUSIONS: This is the first study of gallstone prevalence in Korean UC patients. In this study, patients with UC had a higher prevalence of gallstones compared to that in well-matched healthy controls. Age seemed to be a possible risk factor, and more studies are needed. Further prospective, large-scale studies will be required to confirm the risk factors for gallstones in UC patients.
Asymptomatic Diseases
;
Body Mass Index
;
Colitis, Ulcerative*
;
Crohn Disease
;
Gallstones*
;
Humans
;
Prevalence
;
Retrospective Studies
;
Risk Factors
8.Alcohol Drinking Increased the Risk of Advanced Colorectal Adenomas.
Yoon Kyung SONG ; Young Sook PARK ; Choon Sik SEON ; Hye Jin LIM ; Byung Kwan SON ; Sang Bong AHN ; Young Kwan JO ; Seong Hwan KIM ; Yun Ju JO ; Ji Hyun LEE ; Seung Chan KIM
Intestinal Research 2015;13(1):74-79
BACKGROUND/AIMS: Age, sex, gene and life style are modulating risks for colon cancer. Although alcohol intake may impact on colorectal adenoma, clear association has not been established yet. We aimed to investigate effects of alcohol consumption on the characteristics of colorectal adenoma. METHODS: Patients who underwent colonoscopic polypectomy of colorectal adenoma in the department of gastroenterology of Eulji hospital through 2005 to 2012, having both blood tests and ultrasound or abdominal CT examination were enrolled. The alcohol drinking patients were subdivided into normal or abnormal laboratory group, and alcoholic liver diseases group. RESULTS: 212 patients with colorectal adenoma were analyzed; advanced adenoma and multiple adenoma were found in 68 (32.0%) and 79 (37.2%) patients. When compared to the nondrinker group (120/212 patients), the alcohol drinker group (92/212 patients) represented significantly high odds ratios (ORs) for advanced adenoma (OR, 2.697; P=0.002), and multiple adenoma (OR, 1.929; P=0.039). Among alcohol drinker (92 patients), the ORs of advanced adenoma were 6.407 (P=0.003) in alcoholic liver diseases group (17 patients), 3.711 (P=0.002) in the alcohol drinker with abnormal lab (24 patients), and 2.184 (P=0.034), in the alcohol drinker with normal lab (51 patients) compared to nondrinker group. CONCLUSIONS: This study showed that alcohol drinking may influence on the development of advanced colorectal adenoma and multiplicity. Especially in the group with alcoholic liver diseases and with abnormal lab presented significantly higher ORs of advanced adenoma.
Adenoma*
;
Alcohol Drinking*
;
Colonic Neoplasms
;
Gastroenterology
;
Hematologic Tests
;
Humans
;
Life Style
;
Liver Diseases, Alcoholic
;
Odds Ratio
;
Tomography, X-Ray Computed
;
Ultrasonography
9.A Case of Adult Onset Still's Disease with Severe Pneumonitis Treated with Anakinra.
Soung Ha CHO ; One Zoong KIM ; Sang Woo CHO ; Dong Min LIM ; Su Kyoung AN ; Choon Kwan KIM
Korean Journal of Medicine 2014;87(2):245-250
Adult onset Still's disease (AOSD) is a systemic autoinflammatory disorder that presents with recurrent fever, extreme fatigue, and joint pain. Pulmonary involvement is not uncommon and, although rare, severe pneumonitis can progress to respiratory failure. Still's disease-associated pneumonitis is generally treated with immunosuppressive agents, but improvement in our understanding of systemic inflammatory processes led us to explore alternative agents. Anakinra is an interleukin-1 receptor antagonist used to treat autoinflammatory disorders resistant to immunosuppressive therapy. Several case reports have demonstrated efficacy of anakinra in treating AOSD, but its relevance in cases complicated with severe pneumonitis has not been examined. Our patient's disease activity was not controlled with systemic steroids and cyclophosphamide. Treatment with anakinra led to a dramatic clinical response. This is the first reported case of AOSD with severe pneumonitis refractory to conventional therapy successfully treated with anakinra.
Arthralgia
;
Cyclophosphamide
;
Fatigue
;
Fever
;
Immunosuppressive Agents
;
Interleukin 1 Receptor Antagonist Protein*
;
Interleukin-1
;
Pneumonia*
;
Respiratory Insufficiency
;
Steroids
;
Still's Disease, Adult-Onset*
10.Gastric Outlet Obstruction Due to Gastric Amyloidosis Mimicking Malignancy in a Patient with Ankylosing Spondylitis.
Choon Sik SEON ; Young Sook PARK ; Yu Min JUNG ; Jeong Ho CHOI ; Byoung Kwan SON ; Sang Bong AHN ; Seong Hwan KIM ; Yun Ju JO
Clinical Endoscopy 2013;46(6):651-655
Amyloidosis is a group of disorders characterized by the extracellular accumulation of insoluble, fibrillar proteins in various organs and tissues. It is classified, on the basis of the identity of the precursor protein, as primary, secondary, or familial amyloidosis. Gastrointestinal amyloidosis usually presents as bleeding, ulceration, malabsorption, protein loss, and diarrhea. However, gastric amyloidosis with gastric outlet obstruction mimicking linitis plastica is rare. We report a case of gastrointestinal amyloidosis with gastric outlet obstruction in a patient with ankylosing spondylitis. The patient was indicated for subtotal gastrectomy because of the aggravation of obstructive symptoms, but refused the operation and was transferred to another hospital. Three months later, the patient died of aspiration pneumonia during medical treatment.
Amyloidosis*
;
Amyloidosis, Familial
;
Diarrhea
;
Gastrectomy
;
Gastric Outlet Obstruction*
;
Hemorrhage
;
Humans
;
Linitis Plastica
;
Pneumonia, Aspiration
;
Spondylitis, Ankylosing*
;
Ulcer

Result Analysis
Print
Save
E-mail